Nasal Aspirate Testing Global Market Report 2026

Nasal aspirate testing is a diagnostic technique where mucus and secretions are collected from the nasal passages to detect pathogens or abnormal cells. The sample is usually obtained using a gentle suction device or syringe to ensure adequate material for analysis, commonly used to identify respiratory infections, including viral and bacterial agents, and guide appropriate treatment.

The key product types of nasal aspirate testing include instruments and consumables. Instruments are devices used to collect and analyze nasal samples for diagnostic purposes. Test types include molecular testing, antigen testing, microbiological culture testing, and allergy testing for pediatric and adult age groups. Applications span infectious diseases, respiratory diseases, and other areas, serving hospitals, diagnostic laboratories, research institutes, and other end users.

Tariffs on imported medical devices, laboratory instruments, and diagnostic reagents have impacted the nasal aspirate testing market by increasing procurement costs for molecular diagnostic instruments and consumables. Regions reliant on global supply chains, particularly North America and Europe, are most affected due to dependence on specialized components and reagents. Hospitals and diagnostic laboratories may experience higher operational costs, especially in molecular and antigen testing segments. However, tariffs are encouraging domestic manufacturing of diagnostic kits, localized reagent production, and innovation in cost-effective testing technologies, strengthening regional diagnostic supply chains over time.

The nasal aspirate testing market research report is one of a series of new reports from The Business Research Company that provides nasal aspirate testing market statistics, including nasal aspirate testing industry global market size, regional shares, competitors with a nasal aspirate testing market share, detailed nasal aspirate testing market segments, market trends and opportunities, and any further data you may need to thrive in the nasal aspirate testing industry. This nasal aspirate testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nasal aspirate testing market size has grown strongly in recent years. It will grow from $1.36 billion in 2025 to $1.47 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rising prevalence of respiratory infections, growth in diagnostic laboratory infrastructure, increasing awareness of early disease detection, expansion of hospital testing capabilities, adoption of molecular diagnostic technologies.

The nasal aspirate testing market size is expected to see strong growth in the next few years. It will grow to $2 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to growing demand for high-sensitivity pathogen detection, increasing investment in rapid point-of-care diagnostics, rising integration of AI-assisted diagnostic analysis, expansion of infectious disease surveillance programs, increasing focus on personalized respiratory treatment approaches. Major trends in the forecast period include increasing adoption of rapid molecular diagnostic testing, rising demand for pediatric respiratory infection screening, growing use of automated sample processing systems, expansion of point-of-care respiratory testing, rising focus on early detection of infectious diseases.

The rising prevalence of respiratory infections is anticipated to drive the growth of the nasal aspirate testing market going forward. Respiratory infections are illnesses caused by viral or bacterial pathogens that impact the nasal passages, throat, and lungs, resulting in symptoms such as cough, fever, and breathing difficulties. The frequency of these infections continues to rise due to the widespread circulation of seasonal respiratory viruses, especially in densely populated and high-contact environments where transmission is more probable. Nasal aspirate testing aids in the effective management of respiratory infections by allowing clinicians to collect concentrated respiratory samples from the nasal passages, which enhances pathogen detection accuracy, facilitates early and precise diagnosis, and supports timely treatment decisions. For example, in June 2024, according to the UK Health Security Agency, a UK-based government agency, around 1,681 patients were admitted to critical care with confirmed influenza in England between week 40 of 2022 and week 15 of 2023. Consequently, the increasing prevalence of respiratory infections is expected to fuel the growth of the nasal aspirate testing market.

Leading companies operating in the nasal aspirate testing market are focusing on developing innovative solutions such as, automated sample preparation systems to increase testing speed, accuracy, and standardization. Automated sample preparation systems are technologies that streamline the collection, processing, and preparation of nasal aspirate samples with minimal manual intervention, helping reduce errors, save time, and improve consistency and accuracy in diagnostic testing. For example, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, launched the Thermo Scientific KingFisher Apex Automated Sample Preparation Solution, an innovative system aimed at simplifying and automating respiratory diagnostic testing. The KingFisher Apex is an advanced automated sample preparation system that combines magnetic particle technology with customizable protocols, allowing labs to process multiple sample types with minimal hands-on time, reduce errors, and accelerate diagnostic turnaround. As a next-generation automated sample preparation system, it features a modular design for scalability, compatibility with a wide range of assays, and built-in software for workflow monitoring and optimization, making it particularly valuable for clinical, research, and high-volume testing environments.

In January 2023, SD Biosensor Inc., a South Korea-based in vitro diagnostics and healthcare technology company, and SJL Partners LLC, a South Korea-based private equity firm, acquired Meridian Bioscience Inc. for an undisclosed sum. Through this acquisition, the consortium sought to accelerate SD Biosensor's strategic expansion into the U.S. in vitro diagnostic market and enhance its global diagnostic capabilities by integrating Meridian's established U.S. distribution network and product portfolio with SD Biosensor's development and manufacturing expertise. Meridian Bioscience Inc. is a US-based life sciences and diagnostics company specializing in nasal aspirate testing.

Major companies operating in the nasal aspirate testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Becton Dickinson Company, bioMerieux SA, Hologic Inc., QuidelOrtho Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., DiaSorin S.p.A., SD Biosensor Inc., Meridian Bioscience Inc., Seegene Inc., Sekisui Diagnostics LLC, QuantuMDx Group Limited, Altona Diagnostics GmbH, Fast Track Diagnostics Ltd., Sherlock Biosciences Inc., Coris BioConcept S.A.

North America was the largest region in the nasal aspirate testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nasal aspirate testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nasal aspirate testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nasal aspirate testing market consists of sales of collection kits, diagnostic reagents and consumables, molecular testing kits, rapid antigen test kits, and laboratory equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nasal Aspirate Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses nasal aspirate testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nasal aspirate testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nasal aspirate testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Instruments; Consumables
• 2) By Test Type: Molecular Testing; Antigen Testing; Microbiological Culture Testing; Allergy Testing
• 3) By Age Group: Pediatric; Adult
• 4) By Application: Infectious Diseases; Respiratory Diseases; Other Applications
• 5) By End-User: Hospitals; Diagnostic Laboratories; Research Institutes; Other End Users
• Subsegments:
• 1) By Instruments: Nasal Aspirate Collection Devices; Suction Pumps And Vacuum Systems; Sample Processing Analyzers; Molecular Diagnostic Instruments; Automated Laboratory Workstations
• 2) By Consumables: Sterile Suction Catheters; Sample Collection Tubes; Transport Media Kits; Reagents And Assay Kits; Disposable Filters And Tips
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Becton Dickinson Company; bioMerieux SA; Hologic Inc.; QuidelOrtho Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Cepheid Inc.; DiaSorin S.p.A.; SD Biosensor Inc.; Meridian Bioscience Inc.; Seegene Inc.; Sekisui Diagnostics LLC; QuantuMDx Group Limited; Altona Diagnostics GmbH; Fast Track Diagnostics Ltd.; Sherlock Biosciences Inc.; Coris BioConcept S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.